FindTrial
Sign In

COMPARATIVE EVALUATION OF ANALGESIC EFFICACY OF TRANSDERMAL BUPRENORPHEN PATCH VERSUS TRANSDERMAL DICLOFENAC PATCH AS POSTOPERATIVE PAIN MANAGEMENT IN LOWER LIMB SURGERIES : A PROSPECTIVE, COMPARATIVE, CLINICAL STUDY.

Comparative Evaluation of Analgesic Efficacy of Transdermal Buprenorphen Patch versus Transdermal Diclofenac Patch as Postoperative Pain Management in Lower Limb Surgeries: A Prospective, Comparative, Clinical Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077883
Enrollment
50
Registered
2024-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: transdermal buprenorphine patch: transdermal buprenorphine patch is applied at the end of lower limb surgery and post operatively vas score is checked, when vas is equal to or more than

Sponsors

Smt Bhikiben Kanjibhai Shah Medical Institute and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to sign the written & informed consent. Age group: 18-70 years Patients posted for major lower limb orthopedic surgeries under subarachnoid block with ASA-1 or ASA-2 grade

Exclusion criteria

Exclusion criteria: Patient’s refusal from taking part in the study. Special populations Pregnant and lactating women History of allergy to drugs Severe kidney and liver disease Patients with neuropathies or nerve injuries Patients with pain due to cause other than presenting disease

Design outcomes

Primary

MeasureTime frame
To compare efficacy of transdermal buprenorphine patch vs transdermal diclofenac patch.Timepoint: Baseline While shifting the patient at 2hours at 4 hours at 6hours at 8 hours at 12 hours at 16 hours at 20 hours at 24 hours—

Secondary

MeasureTime frame
To compare rescue analgesia for transdermal diclofenac patch vas transdermal buprenorphine patchTimepoint: Baseline While shifting the patient at 2hours at 4 hours at 6hours at 8 hours at 12 hours at 16 hours at 20 hours at 24 hours—

Countries

India

Contacts

Public ContactJagrati Thadani

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre

dramitchauhan85@gmail.com9426368170

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026